Indications and Usage
Gynazole·1® (butoconazole nitrate) vaginal cream, 2% is indicated for the local treatment of vulvovaginal candidiasis (infections cause by Candida). The diagnosis should be confirmed by KOH smears and/or cultures.
Gynazole·1 is safe and effective in nonpregnant women; however, the safety and effectiveness of this product in pregnant women has not been established. (For further information, please see our product insert sheet, PRECAUTIONS: Pregnancy.)
Gynazole·1 may weaken latex or rubber products such as condoms and contraceptive diaphragms. Usage within 72 hours of treatment is not recommended.
If clinical symptoms persist after treatment, tests should be repeated to rule out other pathogens, to confirm the original diagnosis, and to rule out other conditions that may predispose a patient to recurrent vaginal yeast infections.
Recurrent vaginal yeast infections, especially those that are difficult to eradicate, can be an early sign of infection with the human immunodeficiency virus (HIV) in women who are considered at risk for HIV infection.
©2004, KV Pharmaceutical Company, All Rights Reserved
 
 
 
Fast Relief
FOR LESS
Give your patients
$15 off their next prescription of
Gynazole·1
  Tell a Friend
Gynazole-1®   Have a friend
  who might be
  suffering from a
  yeast infection?
  Send e-mail
  Got Questions?
  We've Got an Answer!
   Frequently asked
   questions about yeast
   infections, treatments,
   and Gynazole·1. more...
Learn More about other Ther-Rx Products
Anti-infectives
 - Clindesse®
Advanced Prescription
Nutritionals
 - Encora®
Prescription Prenatals
- PreCare Premier™
- PrimaCare®
- PrimaCare® ONE
- PremesisRx®
Iron Deficiency
 - Repliva 21/7™
 
 
Home    |    Search    |    Contact Us    |    Site Directory    |    Gynazole·1 Safety Information
Resource Library    |    Prescribing Information    |    Ther-Rx & Women's Healthcare



© 2009 Therx-Rx Corporation Terms of Use of Site